Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

withdrawn125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Meru Health Program Versus Waitlist Control for Adults With Depression

NCT04738084
completednot_applicable

RCT of Adjunctive Curcumin and the Meru Health Program

NCT04744545
withdrawnnot_applicable

Meru Health Program to Treat Depression in Primary Care

NCT05615662
completednot_applicable

Meru Health Program for Cancer Patients With Depression and Anxiety

NCT05588622

Clinical Trials (4)

Showing 4 of 4 trials
NCT04738084Not Applicable

Meru Health Program Versus Waitlist Control for Adults With Depression

Completed
NCT04744545Not Applicable

RCT of Adjunctive Curcumin and the Meru Health Program

Completed
NCT05615662Not Applicable

Meru Health Program to Treat Depression in Primary Care

Withdrawn
NCT05588622Not Applicable

Meru Health Program for Cancer Patients With Depression and Anxiety

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4